NVS
Novartis AG
Company Overview
| Mkt Cap | $243.79B | Price | $123.79 |
| Volume | 1.66M | Change | +0.96% |
| P/E Ratio | 20.4 | Open | $123.41 |
| Revenue | $50.3B | Prev Close | $122.61 |
| Net Income | $11.9B | 52W Range | $96.06 - $133.55 |
| Div Yield | 3.87% | Target | $122.43 |
| Overall | 50 | Value | -- |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailyNovartis AG (NVS) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $123.79 with a market capitalization of $243.79 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows NVS with a volume of 1.66 million shares. The stock opened up 0.65% from yesterday's close of $122.61. Current analyst estimates project earnings of $8.94 per share for this year, with next year targeting $9.41.
NVS demonstrates neutral technical outlook based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, MRK, JNJ, SNY, GSK.
Key investment considerations for NVS include average overall investment profile. The company offers a dividend yield of 3.869541% and analyst price targets suggest limited upside of -1.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:39 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVS | $123.79 | +1.0% | 1.66M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |